Homepage

Homepage

Header Image Multifield: 
Header Image: 
Support our ovarian cancer appeal
Header Image Link: 
Online donation page
Header Image: 
Animation still image
Header Image Link: 
Watch our latest biomedical animation
Header Image: 
Three scientists photographed in a laboratory
Header Image Link: 
WEHI - brighter together

Welcome to WEHI

Super Content: 
The Brain Cancer Centre researchers

The Brain Cancer Centre

Many minds. One focus.

The Brain Cancer Centre was launched publicly on 25 October 2021. The centre was founded by Carrie’s Beanies 4 Brain Cancer and established in partnership with WEHI with support from the Victorian Government. 

The Brain Cancer Centre brings together the best and brightest minds with a single focus: to improve outcomes for brain cancer patients NOW and in the future. Our world-class research teams will work collaboratively to develop new treatments and trials so that patients diagnosed with brain cancer are given real hope.

Learn more

News

Researchers hope the findings could help reduce the industry’s high drug failure rate. Research boosts 'game-changing' technology to strengthen drug development

Researchers have boosted pioneering technology to show whether potential treatments are worth progressing into human trials, in a game-changing move that could dramatically reduce the high failure rates in drug discovery and development. 
24 May 2022
read more
‘A 3D surface representation showing the inhibitor WM382 (in green) bound within the active site cleft of the pacman’s mouth, the plasmepsinX ( in grey). This event blocks the ability of plasmepsinX to process other parasite proteins required for the entry and exit of red blood cells. World-first 3D insights into malaria parasites strengthen drug discovery pipeline

Revolutionary 3D images have enabled researchers to understand how new anti-malaria compounds kill malaria parasites, paving the way for the next generation anti-malarial treatments. 
16 May 2022
read more
Dr Paola Favuzza will spend a year at MMV in Switzerland as part of the fellowship Fellowship to boost Australia’s drug discovery capabilities

WEHI’s Dr Paola Favuzza has received an MTPConnect Researcher Exchange and Development within Industry (REDI) fellowship, that will provide her with the vital industry experience required to turn basic scientific research into positive outcomes for patients. 
13 May 2022
read more
Antibodies binding the SARS-CoV-2 virus. This research could help reduce the severity of viruses like COVID-19 in the future Sweet discovery could drive down inflammation, cancers and viruses

A WEHI-led study has identified a new enzyme involved in controlling cell death, in findings that could lead to better treatment options for a range of inflammatory conditions, cancers and viruses.
12 May 2022
read more

Events

Associate Professor Jinhua Lu - National University of Singapore
Tue, 24/05/2022 - 4:00pm to Tue, 24/05/2022 - 5:00pm


The origin of nuclear autoimmunity: nucleolin as an autoantibody target and a potential alarmin trigger

Davis Auditorium

Details
A/Prof Matt Ritchie - Epigenetics & Development division
Wed, 25/05/2022 - 1:00pm to Wed, 25/05/2022 - 2:00pm


Adventures in nanopore sequencing: developing new tools for exploring methylation and isoform expression in development and cancer

Davis Auditorium

Details
Professor Charalampos Tzoulis - University of Bergen
Thu, 26/05/2022 - 3:30pm to Thu, 26/05/2022 - 4:30pm


NAD replenishment therapy in Parkinson’s disease: A New Hope?

Online

Details
Dr Keely Bumsted-O’Brien - Scientific Education Office
Mon, 30/05/2022 - 11:00am to Mon, 30/05/2022 - 12:15pm


How do consumers contribute to research?

Davis Auditorium

Details

Empty

Empty